TWIST it but don't spin it

3Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Ross et al report the TWISTER study in which imatinib was stopped in chronic myeloid leukemia patients with undetectable minimal residual disease (UMRD) and show that >40% remained off treatment without recurrence at 2 years.1 © 2013 by The American Society of Hematology.

Cite

CITATION STYLE

APA

Apperley, J. F. (2013). TWIST it but don’t spin it. Blood, 122(4), 470–471. https://doi.org/10.1182/blood-2013-06-506097

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free